Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01031004 · ClinicalTrials.gov registry record · NA
Vistakon Investigational Lens Worn as a Single Use Daily Wear
A NA study of Myopia, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 3
- Study locations
NCT01031004: Completed NA study of Myopia, sponsored by Johnson & Johnson Vision Care.
NCT01031004 is a NA study of Myopia that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 50 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (81% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01031004, a NA study of Myopia, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study is intended to show that the investigational contact lens is clinically equivalent to a currently approved contact lens, when worn as single-use on a daily basis.
Primary Outcome
Investigators examined subjects using a slit lamp and the following scale: 0=none, 1=trace, 2=mild, 3=moderate, 4=severe. This outcome measures the number of eyes that had corneal edema graded 2 or higher at the 1-week visit.
Conditions Studied
Interventions
- DEVICE etafilcon A
- DEVICE narafilcon B
Study Locations (3)
Utah
- - Salt Lake City
Virginia
- - Virginia Beach
Wyoming
- - Laramie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2009-10-01 |
| Est. Completion | 2009-12-01 |
| Phase | NA |
What the finished NCT01031004 record still lists
NCT01031004 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which etafilcon A is the first listed.
NCT01031004 reports a single indexed study location in Utah, Virginia, Wyoming.
Frequently Asked Questions
What is clinical trial NCT01031004 about?
NCT01031004 is a clinical study titled "Vistakon Investigational Lens Worn as a Single Use Daily Wear". This study is intended to show that the investigational contact lens is clinically equivalent to a currently approved contact lens, when worn as single-use on a daily basis.
What is the current status of trial NCT01031004?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2009-10-01. Estimated completion is 2009-12-01.
What conditions does trial NCT01031004 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT01031004?
The interventions under investigation include: etafilcon A (DEVICE), narafilcon B (DEVICE).
Who is sponsoring clinical trial NCT01031004?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01031004 being conducted?
This trial has 3 study locations across Utah, Virginia, Wyoming. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01031004's enrollment target sits among peer trials
50 70th of 90 higher than 16 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI